Voloridge Investment Management, LLC Athenex, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $150,029 - $324,329	-110,316 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $266,902 - $434,951	-89,866 Reduced 44.89%	110,316 $332,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $139,781 - $193,283	-37,677 Reduced 15.84%	200,182 $925,000
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $970,464 - $3.51 Million	237,859 New	237,859 $1.02 Million
Q3 2019 Nov 14, 2019	SELL	$12.16 - $21.0 $283,011 - $488,754	-23,274 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $219,706 - $460,825	23,274 New	23,274 $1 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.